US Stock MarketDetailed Quotes

Edgewise Therapeutics (EWTX)

Watchlist
  • 33.090
  • -0.920-2.71%
Close May 15 15:59 ET
  • 33.090
  • 0.0000.00%
Post 20:01 ET
3.56BMarket Cap-19.93P/E (TTM)

Edgewise Therapeutics (EWTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.35%-42.54M
-31.91%-143.82M
-43.16%-38.59M
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-18.58%-109.03M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.1M
Net income from continuing operations
-20.14%-49.01M
-25.40%-167.8M
-26.61%-50.22M
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
Depreciation and amortization
6.50%590K
-1.05%2.27M
-8.59%575K
-5.32%570K
6.18%567K
5.52%554K
32.22%2.29M
18.01%629K
21.13%602K
15.84%534K
Change In working capital
61.71%-1.82M
-152.03%-5.37M
-61.72%2.66M
-128.21%-709K
-180.30%-2.56M
-105.17%-4.76M
762.05%10.33M
3,553.23%6.94M
158.01%2.51M
1,033.63%3.19M
-Change in prepaid assets
306.02%3.05M
-341.89%-7.96M
-271.08%-2.72M
-264.10%-1.3M
-353.02%-2.47M
-2,246.03%-1.48M
192.65%3.29M
518.73%1.59M
168.37%791K
158.93%977K
-Change in payables and accrued expense
-50.63%-4.67M
-54.01%3.34M
9.98%5.57M
-59.07%778K
-96.02%95K
-48.23%-3.1M
246.02%7.26M
1,615.25%5.06M
-14.91%1.9M
81.38%2.39M
-Change in other current liabilities
-9.50%-196K
-240.00%-748K
-165.65%-193K
-5.59%-189K
-9.36%-187K
-9.15%-179K
-111.54%-220K
351.28%294K
-73.79%-179K
---171K
Cash from discontinued investing activities
Operating cash flow
-12.35%-42.54M
-31.91%-143.82M
-43.16%-38.59M
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-18.58%-109.03M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.1M
Investing cash flow
Cash flow from continuing investing activities
-94.46%2.43M
82.24%-32.79M
137.85%49.76M
40.82%35.72M
-533.97%-162.17M
116.36%43.9M
-279.48%-184.66M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
Net PPE purchase and sale
-490.91%-260K
80.49%-256K
73.36%-73K
82.88%-89K
77.38%-50K
85.19%-44K
77.16%-1.31M
-70.19%-274K
-13.79%-520K
70.88%-221K
Net investment purchase and sale
-93.87%2.69M
82.26%-32.53M
135.12%49.84M
38.34%35.81M
-531.29%-162.12M
116.40%43.94M
-268.78%-183.34M
-21.91%21.2M
8.40%25.88M
794.76%37.59M
Cash from discontinued investing activities
Investing cash flow
-94.46%2.43M
82.24%-32.79M
137.85%49.76M
40.82%35.72M
-533.97%-162.17M
116.36%43.9M
-279.48%-184.66M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
Financing cash flow
Cash flow from continuing financing activities
447.59%12.17M
-21.33%196.09M
37.31%3.98M
-50.23%1.66M
9,542.98%188.23M
-99.08%2.22M
368.82%249.25M
-94.54%2.9M
1,679.62%3.33M
429.00%1.95M
Net common stock issuance
----
-21.65%187.36M
--0
--0
--187.36M
--0
354.50%239.15M
--0
--0
--0
Proceeds from stock option exercised by employees
438.39%12.17M
-15.84%8.73M
37.31%3.98M
-53.23%1.66M
-58.45%831K
17.39%2.26M
1,354.14%10.37M
804.69%2.9M
118,133.33%3.55M
442.01%2M
Net other financing activities
----
----
----
----
----
---38K
-58.79%-262K
--0
---214K
----
Cash from discontinued financing activities
Financing cash flow
447.59%12.17M
-21.33%196.09M
37.31%3.98M
-50.23%1.66M
9,542.98%188.23M
-99.08%2.22M
368.82%249.25M
-94.54%2.9M
1,679.62%3.33M
429.00%1.95M
Net cash flow
Beginning cash position
46.76%61.15M
-51.61%41.67M
2.67%46M
-0.19%43.4M
64.95%49.92M
-51.61%41.67M
291.47%86.1M
35.95%44.81M
36.72%43.49M
-37.25%30.26M
Current changes in cash
-438.43%-27.94M
143.85%19.48M
582.32%15.15M
96.74%2.6M
-149.29%-6.52M
114.79%8.26M
-169.31%-44.43M
-105.91%-3.14M
14.87%1.32M
180.50%13.22M
End cash Position
-33.47%33.21M
46.76%61.15M
46.76%61.15M
2.67%46M
-0.19%43.4M
64.95%49.92M
-51.61%41.67M
-51.61%41.67M
35.95%44.81M
36.72%43.49M
Free cash flow
-12.91%-42.8M
-30.57%-144.07M
-41.99%-38.67M
-24.99%-34.87M
-23.98%-32.63M
-31.20%-37.91M
-12.95%-110.34M
-0.89%-27.23M
-23.89%-27.89M
-25.38%-26.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.35%-42.54M-31.91%-143.82M-43.16%-38.59M-27.04%-34.78M-24.84%-32.58M-32.41%-37.87M-18.58%-109.03M-0.47%-26.96M-24.10%-27.37M-28.99%-26.1M
Net income from continuing operations -20.14%-49.01M-25.40%-167.8M-26.61%-50.22M-19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M
Depreciation and amortization 6.50%590K-1.05%2.27M-8.59%575K-5.32%570K6.18%567K5.52%554K32.22%2.29M18.01%629K21.13%602K15.84%534K
Change In working capital 61.71%-1.82M-152.03%-5.37M-61.72%2.66M-128.21%-709K-180.30%-2.56M-105.17%-4.76M762.05%10.33M3,553.23%6.94M158.01%2.51M1,033.63%3.19M
-Change in prepaid assets 306.02%3.05M-341.89%-7.96M-271.08%-2.72M-264.10%-1.3M-353.02%-2.47M-2,246.03%-1.48M192.65%3.29M518.73%1.59M168.37%791K158.93%977K
-Change in payables and accrued expense -50.63%-4.67M-54.01%3.34M9.98%5.57M-59.07%778K-96.02%95K-48.23%-3.1M246.02%7.26M1,615.25%5.06M-14.91%1.9M81.38%2.39M
-Change in other current liabilities -9.50%-196K-240.00%-748K-165.65%-193K-5.59%-189K-9.36%-187K-9.15%-179K-111.54%-220K351.28%294K-73.79%-179K---171K
Cash from discontinued investing activities
Operating cash flow -12.35%-42.54M-31.91%-143.82M-43.16%-38.59M-27.04%-34.78M-24.84%-32.58M-32.41%-37.87M-18.58%-109.03M-0.47%-26.96M-24.10%-27.37M-28.99%-26.1M
Investing cash flow
Cash flow from continuing investing activities -94.46%2.43M82.24%-32.79M137.85%49.76M40.82%35.72M-533.97%-162.17M116.36%43.9M-279.48%-184.66M-22.46%20.92M8.30%25.36M985.65%37.37M
Net PPE purchase and sale -490.91%-260K80.49%-256K73.36%-73K82.88%-89K77.38%-50K85.19%-44K77.16%-1.31M-70.19%-274K-13.79%-520K70.88%-221K
Net investment purchase and sale -93.87%2.69M82.26%-32.53M135.12%49.84M38.34%35.81M-531.29%-162.12M116.40%43.94M-268.78%-183.34M-21.91%21.2M8.40%25.88M794.76%37.59M
Cash from discontinued investing activities
Investing cash flow -94.46%2.43M82.24%-32.79M137.85%49.76M40.82%35.72M-533.97%-162.17M116.36%43.9M-279.48%-184.66M-22.46%20.92M8.30%25.36M985.65%37.37M
Financing cash flow
Cash flow from continuing financing activities 447.59%12.17M-21.33%196.09M37.31%3.98M-50.23%1.66M9,542.98%188.23M-99.08%2.22M368.82%249.25M-94.54%2.9M1,679.62%3.33M429.00%1.95M
Net common stock issuance -----21.65%187.36M--0--0--187.36M--0354.50%239.15M--0--0--0
Proceeds from stock option exercised by employees 438.39%12.17M-15.84%8.73M37.31%3.98M-53.23%1.66M-58.45%831K17.39%2.26M1,354.14%10.37M804.69%2.9M118,133.33%3.55M442.01%2M
Net other financing activities -----------------------38K-58.79%-262K--0---214K----
Cash from discontinued financing activities
Financing cash flow 447.59%12.17M-21.33%196.09M37.31%3.98M-50.23%1.66M9,542.98%188.23M-99.08%2.22M368.82%249.25M-94.54%2.9M1,679.62%3.33M429.00%1.95M
Net cash flow
Beginning cash position 46.76%61.15M-51.61%41.67M2.67%46M-0.19%43.4M64.95%49.92M-51.61%41.67M291.47%86.1M35.95%44.81M36.72%43.49M-37.25%30.26M
Current changes in cash -438.43%-27.94M143.85%19.48M582.32%15.15M96.74%2.6M-149.29%-6.52M114.79%8.26M-169.31%-44.43M-105.91%-3.14M14.87%1.32M180.50%13.22M
End cash Position -33.47%33.21M46.76%61.15M46.76%61.15M2.67%46M-0.19%43.4M64.95%49.92M-51.61%41.67M-51.61%41.67M35.95%44.81M36.72%43.49M
Free cash flow -12.91%-42.8M-30.57%-144.07M-41.99%-38.67M-24.99%-34.87M-23.98%-32.63M-31.20%-37.91M-12.95%-110.34M-0.89%-27.23M-23.89%-27.89M-25.38%-26.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More